Latest Breaking News On - Braf inhibitor - Page 1 : comparemela.com

Marcia Brose, MD, examines data from the COSMIC-311 study, emphasizing the importance of promptly initiating second-line therapy for patients who have progressed on first-line treatments.

Optimizing therapyCosmic 311Braf mutationsBraf inhibitorBraf v600eTumor shrinkageOcular toxicitiesCardiac toxicities